Jeffrey J. Crooke

Design and Characterization of Optimized Adenosine A_2A/A₁ Receptor Antagonists for the Treatment of Parkinson's Disease

Brian C. Shook, Stefanie Rassnick, Nathaniel Wallace et al. · Journal of Medicinal Chemistry · 2012 · 46 citations · Full text

Medicinal Chemistry, Biochemistry, Functional Selectivity +12

Reduction of dominant or submissive behaviors as models for antimanic or antidepressant drug testing: Technical considerations

Ewa Malatyńska, Albert Pinhasov, Jeffrey J. Crooke et al. · Journal of Neuroscience Methods · 2007 · 44 citations

Experimental Psychopathology, Substance Abuse, Behavioral Sciences +13

α-Substituted <i>N</i>-(Sulfonamido)alkyl-β-aminotetralins:  Potent and Selective Neuropeptide Y Y5 Receptor Antagonists

Mark A. Youngman, James J. McNally, Timothy W. Lovenberg et al. · Journal of Medicinal Chemistry · 2000 · 42 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +13

Reduction of Submissive Behavior Model for antidepressant drug activity testing: study using a video-tracking system

Albert Pinhasov, Jeffrey J. Crooke, Daniel I. Rosenthal et al. · Behavioural Pharmacology · 2005 · 38 citations

Substance Use, Psychotropic Medication, Affective Neuroscience +20

Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists

Brian C. Shook, Devraj Chakravarty, J. Kent Barbay et al. · Bioorganic & Medicinal Chemistry Letters · 2013 · 25 citations · Full text

Molecular Pharmacology, Biochemistry, Medicine +4